Regulation of transgenic class II major histocompatibility genes in murine Langerhans cells.

I-E is a class II major histocompatibility complex molecule normally expressed by Langerhans cells. A series of transgenic mice were developed previously that carry E alpha d gene constructs with promoter-region deletions that cause expression of I-E by different cell types when maintained on a B6 (I-E[-]) genetic background. To study cis-acting gene sequences that regulate expression of class II proteins by Langerhans cells, we identified transgenic I-E expression by tissue immunoperoxidase staining and by epidermal cell suspension immunofluorescence cytometry. Mice with a transgene containing 1.4 kilobase pairs (kb) of flanking sequence 5' to the E alpha initiation site expressed barely detectable levels of I-E on a tiny percentage of Langerhans cells, indicating that sequences promoting Langerhans cell expression of E alpha exist between 2.0 and 1.4 kb 5' of the E alpha initiation site. Removal of an additional 170 bp of 5' flanking sequence caused near-normal levels of expression by approximately one third of epidermal Langerhans cells, which contrasts with studies that showed minimal transgene expression by splenic dendritic cells in these animals. Thus, sequences between 1.4 and 1.23 kb 5' of the E alpha initiation site decrease expression of I-E by epidermal Langerhans cells, but enable I-E expression by splenic dendritic cells. These studies identify Langerhans cell-specific regulatory sequences and genetic regions controlling major histocompatibility complex class II gene expression in Langerhans cells and splenic dendritic cells. The genetic regions identified may be particularly important because differential regulation of class II major histocompatibility complex protein synthesis by Langerhans cells and dendritic cells may be crucial to immune functions of intact animals.

[1]  R. Steinman,et al.  Dendritic cells as antigen-presenting cells in vivo. , 1997, Immunology and cell biology.

[2]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[3]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[4]  R. Flavell,et al.  Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. , 1993, Journal of immunology.

[5]  P. Ricciardi-Castagnoli,et al.  Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo , 1993, The Journal of experimental medicine.

[6]  R. Flavell,et al.  Clonal deletion of V beta 5+ T cells by transgenic I-E restricted to thymic medullary epithelium. , 1993, Journal of immunology.

[7]  R. Steinman,et al.  Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, The Journal of experimental medicine.

[8]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[9]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[10]  R. Steinman,et al.  Identification of proliferating dendritic cell precursors in mouse blood , 1992, The Journal of experimental medicine.

[11]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[12]  R. Steinman,et al.  Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain , 1990, The Journal of experimental medicine.

[13]  R. Steinman,et al.  Dendritic cells pulsed with protein antigens in vitro can prime antigen- specific, MHC-restricted T cells in situ [published erratum appears in J Exp Med 1990 Oct 1;172(4):1275] , 1990, The Journal of experimental medicine.

[14]  P. Marrack,et al.  A role for clonal inactivation in T cell tolerance to Mis-1a , 1990, Nature.

[15]  Ed Palmer,et al.  Positive selection of CD4+ T cells mediated by MHC class ll-bearing stromal cell in the thymic cortex , 1989, Nature.

[16]  Christophe Benoist,et al.  Positive selection of the T cell repertoire: Where and when does it occur? , 1989, Cell.

[17]  R. Flavell,et al.  Selective expression of class II E alpha d gene in transgenic mice. , 1989, Journal of immunology.

[18]  R. Steinman,et al.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells , 1989, The Journal of experimental medicine.

[19]  C. Benoist,et al.  Anatomy of a new B-cell-specific enhancer , 1989, Molecular and cellular biology.

[20]  C. Benoist,et al.  B-cell control region at the 5' end of a major histocompatibility complex class II gene: sequences and factors , 1988, Molecular and cellular biology.

[21]  J. Strominger,et al.  B-cell-specific enhancer activity of conserved upstream elements of the class II major histocompatibility complex DQB gene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Benoist,et al.  Compartmentalization of MHC class II gene expression in transgenic mice , 1988, Cell.

[23]  H. Tony,et al.  Characterization of antigen processing and presentation by resting B lymphocytes. , 1988, Journal of immunology.

[24]  R. Steinman,et al.  Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products. , 1988, The Journal of investigative dermatology.

[25]  G. Schuler,et al.  Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells , 1988, The Journal of experimental medicine.

[26]  R. Palmiter,et al.  Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: An in vivo approach to investigate la gene function , 1987, Cell.

[27]  J. Ting,et al.  Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Unanue,et al.  The basis for the immunoregulatory role of macrophages and other accessory cells. , 1987, Science.

[29]  J. Ting,et al.  Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines. , 1987, Journal of immunology.

[30]  Alessandro Sette,et al.  Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells , 1987, Nature.

[31]  J. Strominger,et al.  Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Buerstedde,et al.  The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants. , 1986, Journal of immunology.

[33]  R. Steinman,et al.  Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes , 1986, The Journal of experimental medicine.

[34]  R. Flavell,et al.  Molecular biology of the H-2 histocompatibility complex. , 1986, Science.

[35]  J. Sprent,et al.  Identity of cells that imprint H–2-restricted T-cell specificity in the thymus , 1986, Nature.

[36]  H. Grey,et al.  Antigen presentation by B cells and its significance in T-B interactions. , 1986, Advances in immunology.

[37]  S. Tonegawa,et al.  Functional expression of a microinjected Edα gene in C57BL/6 transgenic mice , 1985, Nature.

[38]  R. Palmiter,et al.  Tissue‐specific, inducible and functional expression of the E alpha d MHC class II gene in transgenic mice. , 1985, The EMBO journal.

[39]  C. Benoist,et al.  Correcting an immune-response deficiency by creating Eα gene transgenic mice , 1985, Nature.

[40]  G. Widera,et al.  Organization and Expression of the MHC of the C57 Black/10 Mouse , 1985, Immunological reviews.

[41]  R. Steinman,et al.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.

[42]  S. Tonegawa,et al.  Cell type-specific enhancer element associated with a mouse MHC gene, Eβ , 1984, Nature.

[43]  Z. Cohn,et al.  Studies of the cell surface of mouse dendritic cells and other leukocytes , 1981, The Journal of experimental medicine.

[44]  K. Ozato,et al.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. , 1980, Journal of immunology.

[45]  P. Askenase,et al.  Role of antigen-presenting cells in the development and persistence of contact hypersensitivity , 1980, The Journal of experimental medicine.

[46]  E. Shevach,et al.  Immunologic functions of Ia-bearing epidermal Langerhans cells. , 1978, Journal of immunology.

[47]  E. Shevach,et al.  Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. , 1978, The Journal of investigative dermatology.